1h Free Analyst Time
The vaccines market is forecasted to grow by USD 193.7 billion during 2024-2029, accelerating at a CAGR of 23% during the forecast period. The report on the vaccines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased funding for vaccine development and new vaccine launches, need for novel vaccines for chronic infections, and increasing use of adjuvants in vaccines.
The vaccines market is segmented as below:
By Type
- Human vaccine
- Animal vaccine
By End-user
- Hospitals
- Clinics
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the vaccines market covers the following areas:
- Vaccines Market sizing
- Vaccines Market forecast
- Vaccines Market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Type
9 Market Segmentation by End-user
10 Customer Landscape
11 Geographic Landscape
12 Drivers, Challenges, and Opportunity/Restraints
13 Competitive Landscape
14 Competitive Analysis
15 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global vaccines market: Astellas Pharma Inc., AstraZeneca Plc, Bavarian Nordic AS, Bharat Biotech Ltd., BrightPath Biotherapeutics Co., Ltd., CSL Ltd., Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc., GSK Plc, Gradalis Inc., Inovio Pharmaceuticals Inc., Johnson and Johnson Inc., Merck KGaA, Mitsubishi Chemical Group Corp., Novavax Inc., Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., Takeda Pharmaceutical Co. Ltd., and Valneva SE.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is development of nanoparticle vaccines."
According to the report, one of the major drivers for this market is the increased funding for vaccine development and new vaccine launches.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Astellas Pharma Inc.
- AstraZeneca Plc
- Bavarian Nordic AS
- Bharat Biotech Ltd.
- BrightPath Biotherapeutics Co. Ltd.
- CSL Ltd.
- Daiichi Sankyo Co. Ltd.
- Emergent BioSolutions Inc.
- GSK Plc
- Gradalis Inc.
- Inovio Pharmaceuticals Inc.
- Johnson and Johnson Inc.
- Merck KGaA
- Mitsubishi Chemical Group Corp.
- Novavax Inc.
- Pfizer Inc.
- Sanofi SA
- Serum Institute of India Pvt. Ltd.
- Takeda Pharmaceutical Co. Ltd.
- Valneva SE
